DDInter1285 DDInter122
A potent, non-nucleoside reverse transcriptase inhibitor (NNRTI) used in combination with nucleoside analogues for treatment of Human Immunodeficiency Virus Type 1 (HIV-1) infection and AIDS. Structurally, nevirapine belongs to the dipyridodiazepinone chemical class.
Artesunate is indicated for the initial treatment of severe malaria. The World Health Organization recommends artesunate as first line treatment for severe malaria. Artesunate was developed out of a need for a more hydrophilic derivative of [artemisinin]. Artesunate was granted FDA approval on 26 May 2020.
Nevirapine {u} (Compound) treats {v} (Disease) acquired immunodeficiency syndrome
Nevirapine {u} (Compound) binds {v} (Gene) CYP3A5
Nevirapine {u} (Compound) is included by {v} (Pharmacologic Class) Non-Nucleoside Reverse Transcriptase Inhibitors
Nevirapine {u} (Compound) causes {v} (Side Effect) Hypersensitive syndrome
Nevirapine {u} may cause a minor interaction that can limit clinical effects when taken with {v} Prasugrel
Nevirapine {u} may cause a minor interaction that can limit clinical effects when taken with {v} Bortezomib
Nevirapine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Cisapride
Nevirapine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Pegaspargase
Nevirapine {u} may lead to a major life threatening interaction when taken with {v} Brigatinib
Nevirapine (Compound) treats acquired immunodeficiency syndrome (Disease)
Nevirapine (Compound) binds CYP3A5 (Gene)
Nevirapine (Compound) is included by Non-Nucleoside Reverse Transcriptase Inhibitors (Pharmacologic Class)
Nevirapine (Compound) causes Hypersensitive syndrome (Side Effect)
Nevirapine may cause a minor interaction that can limit clinical effects when taken with Prasugrel
Nevirapine may cause a minor interaction that can limit clinical effects when taken with Bortezomib
Nevirapine may cause a moderate interaction that could exacerbate diseases when taken with Cisapride
Nevirapine may cause a moderate interaction that could exacerbate diseases when taken with Pegaspargase
Nevirapine may lead to a major life threatening interaction when taken with Brigatinib